Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

DALBHARAT - Investment Analysis: Buy Signal or Bull Trap?

Last Updated Time : 20 Dec 25, 07:05 am

Back to Investment List

Investment Rating: 1.8

Stock Code DALBHARAT Market Cap 37,755 Cr. Current Price 2,013 ₹ High / Low 2,496 ₹
Stock P/E 288 Book Value 415 ₹ Dividend Yield 0.44 % ROCE 2.56 %
ROE 2.36 % Face Value 2.00 ₹ DMA 50 2,078 ₹ DMA 200 2,089 ₹
Chg in FII Hold 0.52 % Chg in DII Hold 0.44 % PAT Qtr 14.0 Cr. PAT Prev Qtr 33.0 Cr.
RSI 47.6 MACD -5.42 Volume 1,44,232 Avg Vol 1Wk 1,92,332
Low price 1,601 ₹ High price 2,496 ₹ PEG Ratio -90.9 Debt to equity 0.00
52w Index 46.0 % Qtr Profit Var 40.0 % EPS 6.98 ₹ Industry PE 33.2

📊 Analysis: DALBHARAT shows weak fundamentals for long-term compounding. ROE at 2.36% and ROCE at 2.56% are far below ideal thresholds. Valuation is extremely stretched with P/E at 288 compared to industry average of 33.2, and PEG ratio (-90.9) highlights poor growth-adjusted valuation. Dividend yield at 0.44% is modest, while debt-to-equity at 0.00 reflects a debt-free balance sheet. EPS at 6.98 ₹ is low relative to market cap. Technicals show RSI at 47.6 (neutral), MACD negative (-5.42), and price hovering near both 50 DMA (2,078 ₹) and 200 DMA (2,089 ₹), indicating consolidation with bearish bias. Quarterly PAT dropped sharply (33 Cr. to 14 Cr.), raising concerns about earnings sustainability.

💡 Entry Zone: Safer entry would be in the 1,600–1,750 ₹ range, aligning with valuation comfort and support levels. Current price (2,013 ₹) is well above fair entry zone, making risk-reward unattractive.

📈 Exit Strategy: If already holding, consider tactical exit near 2,100–2,200 ₹ resistance. Long-term holding is not favorable unless ROE improves above 12–15% and earnings growth stabilizes. Suggested holding period: short-term (6–12 months) rather than multi-year compounding.

Positive

Limitation

Company Negative News

Company Positive News

Industry

Conclusion

🔎 DALBHARAT is not a strong candidate for long-term investment due to weak ROE/ROCE and stretched valuations. Entry should be avoided at current levels; wait for correction near 1,600–1,750 ₹. Existing holders may exit near resistance zones or hold short-term only. Long-term compounding potential is limited unless profitability metrics improve significantly.

Would you like me to extend this into a peer benchmarking overlay comparing DALBHARAT against cement sector peers like Ultratech, Shree Cement, and Ramco Cements to highlight relative valuation comfort zones?

Back to Investment List

NIFTY 50 - Today Top Investment Picks Stock Picks

NEXT 50 - Today Top Investment Picks Stock Picks

MIDCAP - Today Top Investment Picks Stock Picks

SMALLCAP - Today Top Investment Picks Stock Picks